Mayne Pharma Group Limited

MAYNF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents$59,839$53,710$110,068$109,227
Short-Term Investments$40,564$71,200$39,210$45,584
Receivables$164,619$175,939$193,222$171,239
Inventory$50,561$61,057$74,629$91,904
Other Curr. Assets$20,840$67,591$24,265$57,349
Total Curr. Assets$352,792$429,497$460,593$475,303
Property Plant & Equip (Net)$58,869$57,499$53,326$50,353
Goodwill$0$0$0$0
Intangibles$542,106$576,006$568,580$583,265
Long-Term Investments$0$0$15,337$0
Tax Assets$0$0$45,341$27,914
Other NC Assets$60,838$67,733$0$16,856
Total NC Assets$661,813$701,238$682,584$678,388
Other Assets$0$0$0$0
Total Assets$1,014,605$1,130,735$1,143,177$1,153,691
Liabilities
Payables$30,252$27,263$20,874$42,774
Short-Term Debt$35,152$33,350$31,641-$7,098
Tax Payable$0$0$0$1,165
Deferred Revenue$0$0$6,536$7,098
Other Curr. Liab.$51,729$70,852$71,214$69,301
Total Curr. Liab.$261,011$305,869$313,938$295,658
LT Debt$0$0$31,641$30,019
Deferred Rev, NC$0$0$0$5,726
Deferred Tax Liab, NC$0$0$7,352$7,176
Other NC Liab.$380,656$375,854$332,698$264,251
Total NC Liab.$383,311$378,662$375,051$310,260
Other Liabilities$0$0$0$0
Cap. Leases$6,119$6,515$7,180$3,088
Total Liabilities$644,322$684,531$688,989$605,918
Equity
Pref Stock$0$0$0$0
Common Stock$1,225,979$1,225,655$1,224,224$1,223,920
Retained Earnings-$1,040,982-$969,548-$944,003-$840,322
AOCI$185,286$190,097$173,967$164,175
Other Equity$0$0$0$0
Total Equity$370,283$446,204$454,188$547,773
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,014,605$1,130,735$1,143,177$1,153,691
Net Debt-$24,687-$20,360-$46,786-$86,306